1-11788023-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001010881.2(C1orf167):​c.3824G>A​(p.Ser1275Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00133 in 1,301,232 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 3 hom. )

Consequence

C1orf167
NM_001010881.2 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.51

Publications

3 publications found
Variant links:
Genes affected
C1orf167 (HGNC:25262): (chromosome 1 open reading frame 167) Implicated in coronary artery disease. [provided by Alliance of Genome Resources, Apr 2022]
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0053456426).
BP6
Variant 1-11788023-G-A is Benign according to our data. Variant chr1-11788023-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 292189.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C1orf167NM_001010881.2 linkc.3824G>A p.Ser1275Asn missense_variant Exon 18 of 21 ENST00000688073.1 NP_001010881.1 Q5SNV9A2VCK6A0A8I5KXP5Q8NDG0
MTHFRNM_005957.5 linkc.*2657C>T 3_prime_UTR_variant Exon 12 of 12 ENST00000376590.9 NP_005948.3 P42898-1Q8IU67Q59GJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C1orf167ENST00000688073.1 linkc.3824G>A p.Ser1275Asn missense_variant Exon 18 of 21 NM_001010881.2 ENSP00000510540.1 A0A8I5KXP5
MTHFRENST00000376590.9 linkc.*2657C>T 3_prime_UTR_variant Exon 12 of 12 1 NM_005957.5 ENSP00000365775.3 P42898-1

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
182
AN:
152232
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00207
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.00125
AC:
185
AN:
147914
AF XY:
0.00119
show subpopulations
Gnomad AFR exome
AF:
0.000447
Gnomad AMR exome
AF:
0.000294
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00175
Gnomad NFE exome
AF:
0.00184
Gnomad OTH exome
AF:
0.00118
GnomAD4 exome
AF:
0.00135
AC:
1551
AN:
1148882
Hom.:
3
Cov.:
31
AF XY:
0.00135
AC XY:
763
AN XY:
563252
show subpopulations
African (AFR)
AF:
0.000206
AC:
5
AN:
24294
American (AMR)
AF:
0.000253
AC:
7
AN:
27690
Ashkenazi Jewish (ASJ)
AF:
0.00179
AC:
28
AN:
15670
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12812
South Asian (SAS)
AF:
0.00108
AC:
82
AN:
75854
European-Finnish (FIN)
AF:
0.00165
AC:
45
AN:
27298
Middle Eastern (MID)
AF:
0.00342
AC:
15
AN:
4380
European-Non Finnish (NFE)
AF:
0.00143
AC:
1314
AN:
919422
Other (OTH)
AF:
0.00133
AC:
55
AN:
41462
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
92
184
276
368
460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00119
AC:
182
AN:
152350
Hom.:
0
Cov.:
33
AF XY:
0.00102
AC XY:
76
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41586
American (AMR)
AF:
0.000327
AC:
5
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00207
AC:
141
AN:
68034
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00155
Hom.:
0
Bravo
AF:
0.00110
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00104
AC:
4
ExAC
AF:
0.00118
AC:
28
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Homocystinuria due to methylene tetrahydrofolate reductase deficiency Uncertain:1
Jun 11, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

not provided Benign:1
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

C1orf167: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
8.3
DANN
Benign
0.87
DEOGEN2
Benign
0.0018
T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.28
N
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.0053
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
1.5
PROVEAN
Benign
-0.94
N
REVEL
Benign
0.071
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.14
T
Polyphen
0.57
P
Vest4
0.044
MVP
0.067
MPC
0.55
ClinPred
0.027
T
GERP RS
2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.027
gMVP
0.078
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371188005; hg19: chr1-11848080; COSMIC: COSV57172189; COSMIC: COSV57172189; API